Weitzman Deborah's Form 4 filing
Cardinal Health IncCAH · filed Aug 29, 2023
- Accession no.
- 0000721371-23-000082
- Filed
- Aug 29, 2023
- Trade date
- Aug 28, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $602.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weitzman DeborahCIK 0001942639 | Officer (CEO, Pharmaceutical Segment) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | Common Shares | MOption exerciseAcquired | +6,712 | $71.43 | +$479,438.16 | 50,914 | Direct | |
| Aug 28, 2023 | Common Shares | SSaleDisposed | −6,712 | $89.81 | −$602,804.72 | 44,202 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2023 | Common Shares | MOption exerciseDisposed | −6,712 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.